Showing results (71-80 of 279) with videos related to
Sort By:
Pageof 28
Revista Da Associacao Medica Brasileira (1992)|April 1, 1996
[The tragus as a donor area of cartilage grafts: anatomic study]L C Ishida, M D Pereira, J M AndrewsThe Journal of Antimicrobial Chemotherapy|January 1, 1994
The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg poC Catchpole, J M Andrews, J Woodcock, et al.Antimicrobial Agents and Chemotherapy|December 26, 2001
Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudateR Wise, T Gee, G Marshall, et al.Internal Medicine Journal|May 8, 2010
Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in AustraliaW Connell, J M Andrews, S Brown, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1992
The in-vitro activity of two new quinolones: rufloxacin and MF 961R Wise, J M Andrews, R Matthews, et al.The Journal of Antimicrobial Chemotherapy|May 1, 1990
Pharmacokinetics and tissue penetration of cefprozilK Nye, P O'Neill, J M Andrews, et al.Antimicrobial Agents and Chemotherapy|December 1, 1982
Pharmacokinetics and tissue penetration of azthreonamR Wise, A Dyas, A Hegarty, et al.Antimicrobial Agents and Chemotherapy|June 1, 1991
Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillinR Wise, M Logan, M Cooper, et al.Antimicrobial Agents and Chemotherapy|July 1, 1987
Pharmacokinetics and tissue penetration of roxithromycin after multiple dosingR Wise, B Kirkpatrick, J Ashby, et al.The Medical Journal of Australia|August 7, 1995
Inflammatory bowel disease: a retrospective review of a specialist-based cohortJ M Andrews, I Norton, O Dent, et al.Pageof 28